Stockholders' Deficiency (Details Narrative) (USD $)	3 Months Ended		9 Months Ended
	Sep. 30, 2014	Sep. 30, 2013	Sep. 30, 2014	Sep. 30, 2013	Dec. 31, 2013
Accrued contractual dividends	$ 224,189		$ 224,189		$ 279,380
Selling, general and administrative expenses	1,317,775	2,166,749	3,686,421	6,102,298
Incremental shares of common stock	2,584,748		2,584,748
Private Placement [Member]
Principle recieved	1,303,000		1,303,000
Expenses	94,241		94,241
Shares unit sold	8,686,670		8,686,670
Shares price	$ 0.15		$ 0.15
Stock Option [Member]
Fair value of shares issued as compensation			10,646
Weighted average fair value of the stock options granted	$ 0.17	$ 0.00	$ 0.17	$ 1.17
Selling, general and administrative expenses	99,940	143,113	358,144	469,356
Stock-Based compensation expense related to stock options			1,259,673
Stock based compensation expense, unamortized			368,104
Weighted Average Remaining Period			1 year 1 month 6 days
Stock based compensation expense, unamortized, performance based stock option			891,569
Stock Warrants [Member]
Weighted average fair value of the stock options granted	$ 0.22		$ 0.23	$ 1.36
Selling, general and administrative expenses	134,205	20,424	133,618	493,940
Stock-Based compensation expense related to stock options			578,762
Stock based compensation expense, unamortized			1,922
Weighted Average Remaining Period			1 year
Grant date value performance based warrant, unamortized			576,840
Salary expense			$ 116,667